|
1ZEA
Structure of the anti-cholera toxin antibody Fab fragment TE33 in complex with a D-peptide
Deposited 2005-04-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
1–216(216 aa)
|
Not recorded
|
CIT CITRIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;PEG 8000, citrat buffer, potassium chloride, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.78 Å
R-free 0.248
|
|
2DTM
Thermodynamic and structural analyses of hydrolytic mechanism by catalytic antibodies
Deposited 2006-07-13
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
1–219(219 aa)
Fragment:FAB FRAGMENT
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.7;293 K;50mM Tris-HCl(pH 8.7), 16%(w/v) PEG4000, 0.1mM EDTA, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.25 Å
R-free 0.278
|
|
2IPT
PFA1 Fab Fragment
Deposited 2006-10-12
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
1–219(219 aa)
|
Not recorded
|
ACM ACETAMIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;294 K;0.1 M Hepes, 25% PEG3350, pH 7.5, VAPOR DIFFUSION, temperature 294K
|
Resolution 2.00 Å
R-free 0.223
|
|
2R0W
PFA2 FAB complexed with Abeta1-8
Deposited 2007-08-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
1–219(219 aa)
Fragment:light chain
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.3;295 K;25% PEG-MME 5000, 0.1 M OAc, pH 5.3, VAPOR DIFFUSION, temperature 295K
|
Resolution 2.50 Å
R-free 0.277
|
|
2R0Z
PFA1 FAB complexed with GripI peptide fragment
Deposited 2007-08-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
1–219(219 aa)
Fragment:light chain
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;295 K;PEG, VAPOR DIFFUSION, temperature 295K
|
Resolution 2.10 Å
R-free 0.261
|
|
3EYS
PFA1 Fab fragment complexed with pyro-Glu3-A-Beta (3-8)
Deposited 2008-10-21
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
1–219(219 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;298 K;25% w/v PEG2000-MME, pH 8.5, vapor diffusion, sitting drop, temperature 298K
|
Resolution 1.95 Å
R-free 0.256
|
|
3EYU
PFA1 Fab fragment complexed with Ror2(518-525)
Deposited 2008-10-21
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
1–219(219 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;20% w/v PEG3350, 0.2 M LiCl, vapor diffusion, sitting drop, temperature 298K
|
Resolution 2.71 Å
R-free 0.248
|
|
4P3D
MT1-MMP:Fab complex (Form II)
Deposited 2014-03-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
1–217(217 aa)
Chain L
1–217(217 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
GOL GLYCEROL × 2
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2
EDO 1,2-ETHANEDIOL × 3
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;25% PEG 3350, 0.2M MgCl.hexahydrate, 0.1M Hepes
|
Resolution 1.95 Å
R-free 0.210
|
|
4TPR
Structure of Tau5 antibody Fab fragment
Deposited 2014-06-09
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: Dimeric
|
Chain L
1–218(218 aa)
|
Not recorded
|
PG4 TETRAETHYLENE GLYCOL × 2
CL CHLORIDE ION × 5
PGE TRIETHYLENE GLYCOL × 1
NA SODIUM ION × 1
PEG DI(HYDROXYETHYL)ETHER × 5
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
33O 3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaoctatriacontane-1,38-diol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;295 K;0.2 M NaCl, 0.1 M Bis-Tris, 25 % w/v PEG 3350
|
Resolution 1.60 Å
R-free 0.191
|
|
4TQE
Structure of tau peptide in complex with Tau5 antibody Fab fragment
Deposited 2014-06-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
1–218(218 aa)
|
Not recorded
|
SO4 SULFATE ION × 5
NA SODIUM ION × 4
PGE TRIETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2M lithium sulphate, 30% PEG 4000, 0.1M Tris pH 8.5
|
Resolution 1.60 Å
R-free 0.197
|
|
6PXR
Anti-TAU BIIB092 FAB with TAU peptide
Deposited 2019-07-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
103–219(117 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;100 mM Tris-HCl, pH 8.5, 20% w/v PEG2000 MME, 200 mM trimethylamine N-oxide, 100 mM non-detergent sulfobetaine 201
|
Resolution 1.56 Å
R-free 0.268
|
|
7A6C
Nanodisc reconstituted human ABCB1 in complex with MRK16 Fab and elacridar
Deposited 2020-08-25
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–219(219 aa)
|
Not recorded
|
R0Z elacridar × 2
CLR CHOLESTEROL × 10
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|